Odyssey Health, Inc.
ODYY · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | -0.25 | -0.05 | 0.03 |
| FCF Yield | -3.60% | -2.29% | -0.61% | -2.07% |
| EV / EBITDA | 82.40 | -21.06 | -13.82 | -26.86 |
| Quality | ||||
| ROIC | 5.85% | 3.11% | 2.73% | 3.48% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.59 | 0.19 | 0.02 | 0.21 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | 145,332.71% | 145,332.71% |
| Free Cash Flow Growth | -489.21% | -1,105.00% | 91.43% | 81.22% |
| Safety | ||||
| Net Debt / EBITDA | 16.33 | -10.16 | -10.37 | -12.49 |
| Interest Coverage | -0.50 | -2.63 | -2.10 | -2.47 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |